Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer

Published:2015-07 Issue:1 Volume:68 Page:42-50
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fizazi Karim,Massard Christophe,Smith Matthew,Rader Michael,Brown Janet,Milecki Piotr,Shore Neal,Oudard Stephane,Karsh Lawrence,Carducci Michael,Damião Ronaldo,Wang Huei,Ying Wendy,Goessl Carsten

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. Globocan. Prostate cancer estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.

2. Prostate cancer: ESMO Consensus Conference Guidelines 2012;Horwich;Ann Oncol,2013

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Recent developments in treatments targeting castration-resistant prostate cancer bone metastases;Loriot;Ann Oncol,2012

5. Targeting continued androgen receptor signaling in prostate cancer;Massard;Clin Cancer Res,2011

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel bone-resorption markers by osteoclastsin vitroandin vivo;2024-05-10

2. A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer;Clinical Cancer Research;2024-04-29

3. Evidence-Based Nonpharmacological Symptom Management of Palliative Care in Advanced and Metastatic Cancer Patients: A Systematic Review;Florence Nightingale Journal of Nursing;2024-02-28

4. The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide;Cancers;2024-02-13

5. Prostate Cancer Survival Analysis of 872 Patients in Southern Iran: A Retrospective Cohort Study;MIDDLE EAST J CANCER;2023